Integrated Causal Inference and Transcriptomics Data on ChREBP in Diabetic Kidney Disease

A research document by Mingliang Liu, last updated in April 2026, integrates genetic inference, kidney transcriptomics, and experimental validation to investigate the role of the ChREBP transcription factor in diabetic kidney disease. The 16.5 KB file contains methodological details and results from analyses including two-sample Mendelian randomization and gene set enrichment studies. The data originates from genetic and transcriptomic studies, including the GSE30529 dataset and experiments with db/db mice and primary cells.

Use Cases

• Validate causal gene-disease relationships based on Mendelian randomization methods described.
• Analyze metabolic and profibrotic pathway activity based on MLXIPL expression stratification mentioned.
• Study gene regulatory networks in kidney disease based on the network inference approach outlined.
• Correlate transcriptomic signatures with experimental validation in model systems described.

Strengths

• Document is under a permissive CC-BY-4.0 license.
• Research integrates multiple methodological approaches: Mendelian randomization, transcriptomics, and experimental validation.
• Last update is dated 2026-04-15, indicating recent activity.

Limitations

• The 16.5 KB size suggests the file is a document, not a primary data repository.
• Row count and column-level documentation are absent; data structure must be inferred.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare

Collection Method

Integrated analysis of published genetic data, transcriptomic datasets (e.g., GSE30529), and original experimental validation.

Time Range

null

Freshness

Last updated 2026-04-15 05:43:03.

Geography

null